Our product A.I.M® 434 in scientific U.S. press
The Journal JVS-VL of Society for Vascular Surgery and the American Venous Forum published this abstract on A.I: from a presentation in Orlando, FL, from
30. Mai 2022
We are VeinBrain®
We are international experts in intelligent scientific analysis, powerful medical software and data processing, the creation of artificial intelligence and blockchain technologies.
IntraShape® achieves normalization of vein valves and vein walls by re-shaping
diseased elements with natural substances such as hyaluronan gel.
Patented worldwide!
News & updates
On these pages you will find some of the current news. Please use the contact form to ask for specific information.
If you like these news, please subscribe to our newsletter to receive even better information.
First publication in Switzerland – VASA 2022
Famous European Journal VASA published an abstract from the 2021 meeting of the Swiss Society for Vascular Diseases (USGG, Union der Schweizer Gesellschaften für Gefässmedizin),
30. Mai 2022
First scientific publication on A.I.M® 434
The first full-text publication in artificial intelligence used for detection and time scale development of early stages of venous insufficiency, printed in the Egyptian Journal
30. Mai 2022
Current
products
Patient information software
In collaboration with skilled designers, programmers, SEO specialists and ethical counselors we develop websites and advertizing tools for selected medical customers.
Google Customer Satisfaction Software
This program selection aims at the large community of Google-using customers to improve their search experience and increase their satisfaction.
Management Software
Our management sortware products are particularely custom-tailored to please all those who prefer real-time data on all their business progress. And it prepares revenues and even final reports „on the fly“.
Medical Business Software
With products like MED24 or CITO! we support clinics and medical facilities to establish and maintain an optimal workflow with a minimum of staff.
Artificial Intelligence Medical Software
Our trademark A.I.M® stands for Artificial Intelligence in Medicine. We care about A.I. products for medical research, diagnostics and therapy in fields where human and artificial intelligence meet on highest levels.
Patient Information Printware
All our software-based information is also available in printed or printable formats. Ask for a free sample.
investment
you are Interested
in investing?
The VENARTIS® group, due to ist history, has a primary focus on venous diseases. The originator of many or our projects was renowned Mr. Johann Chris Ragg, MD, founder of the European chain of angioclinic vein centers. He spent more than 25 years in intense research of vascular diseases and was the holder of dozens of medical patents worldwide. Today, VENARTIS® owns and continues his projects on a professional business level.
Investors are welcome to participate in the tremendous proceedings of vein therapy, which currently changes from surgery to minimally invasive techniques, and to effective prevention. There is no company in the world offering strategies and products for ALL relevant branches of phlebology, with several multi-billion-markets to be conquered right now.
Please use the contact form to submit a message
and receive more specific information.
You are a patient?
If you visit these pages because some information on vein disease raised your attention,
please use the contact form to submit a message and receive more specific information.
By the way, according to the medical research teams working for the VENARTIS® group,
vein diseases are not what everybody else will tell you. Core news: Most vein diseases are not at all chronic,
but pretty well preventable and fully curable – with our knowledge.
our team is ready
To help
VeinBrain GmbH
-
Chaltenbodenstrasse 16
CH - 8834 Schindellegi
Gem. Feusisberg (SZ)
CEO
- Karolina Pahlitzsch
- Email: ceo@veinbrain.ch
- Phone: +41 438 44 44 73